Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 6:41 PM
Ignite Modification Date:
2025-12-25 @ 4:12 PM
NCT ID:
NCT01891357
Group ID:
EG000
Title:
Paclitaxel + Lapatinib + Trastuzumab
Description:
Paclitaxel 80 mg/m2 weekly for 12 weeks with lapatinib 750 mg P.O. daily and trastuzumab 2 mg/kg IV (loading dose 4 mg/kg) weekly for 12 weeks, biopsy before and after three weeks of study treatment
Biopsy before and after three weeks of study treatment: Core biopsies for histological analyses, to be analysed by the central pathology
paclitaxel
lapatinib
trastuzumab
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
16
Serious Number At Risk:
61
Other Number Affected:
59
Other Number At Risk:
61
Study:
NCT01891357
Results Section:
NCT01891357
Adverse Events Module:
NCT01891357